Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-14

FDA Tentative Approval: LAMIVUDINE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA issued tentative approval for Strides Pharma Science Limited's generic lamivudine under an ANDA, signaling potential US market approval subject to remaining…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

SUPPL TA for LAMIVUDINE (LAMIVUDINE)